Cited by 300Cytokine Signaling Pathways and InteractionsReproductive System and PregnancyPregnancy and preeclampsia studies

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3

Open access
Roberts, Andrew W., Robb, Lorraine, Rakar, Steven, Hartley, Lynne, Cluse, Leonie, Nicola, Nicos A., Metcalf, Donald, Hilton, Douglas J. +1 more·2001·Proceedings of the National Academy of Sciences

Abstract

Mice lacking suppressor of cytokine signaling 3 (SOCS3) exhibited embryonic lethality with death occurring between days 11 and 13 of gestation. At this stage, SOCS3 −/− embryos were slightly smaller than wild type but appeared otherwise normal, and histological analysis failed to detect any anatomical abnormalities responsible for the lethal phenotype. Rather, in all SOCS3 −/− embryos examined, defects were evident in placental development that would account for their developmental arrest and death. The placental spongiotrophoblast layer was significantly reduced and accompanied by increased numbers of giant trophoblast cells. Delayed branching of the chorioallantois was evident, and, although embryonic blood vessels were present in the labyrinthine layer of SOCS3 −/− placentas, the network of embryonic vessels and maternal sinuses was poorly developed. Yolk sac erythropoiesis was normal, and, although the SOCS3 −/− fetal liver was small at day 12.5 of gestation (E12.5), normal frequencies of erythroblasts and hematopoietic progenitor cells, including blast forming unit-erythroid (BFU-E) and, colony forming unit-erythroid (CFU-E) were present at both E11.5 and E12.5. Colony formation for both BFU-E and CFU-E from SOCS3 −/− mice displayed wild-type quantitative responsiveness to erythropoietin (EPO), in the presence or absence of IL-3 or stem cell factor (SCF). These data suggest that SOCS3 is required for placental development but dispensable for normal hematopoiesis in the mouse embryo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.161271798

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [22]Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. P., Metcalf, D. & Begley, C. G. (1995) Proc. Natl. Acad. Sci. USA 92, 7075-7079.

Cited by

Sorted by citations

Authors
Roberts, A. W., Robb, L., Rakar, S., Hartley, L., Cluse, L., Nicola, N. A., Metcalf, D., Hilton, D. J., & Alexander, W. S.
Affiliations
The Royal Melbourne Hospital (AU)
Venue
Proceedings of the National Academy of Sciences
Published
2001-07-31
Volume
98
Issue
16
Pages
9324-9329
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2040810264
Cited by
300
References
2
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 8 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 9 · 2014: 11 · 2013: 17 · 2012: 23
FWCI
9.86
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R37CA022556, CA22556, R01CA022556)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
SOCS3, embryonic lethality, placental development, spongiotrophoblast, fetal liver hematopoiesis, BFU-E, CFU-E, erythropoietin, stem cell factor, interleukin-3, hematopoietic progenitor cells, mouse embryo
MeSH terms
Suppressor of Cytokine Signaling 3 Protein, Animals, Base Sequence, Erythropoietin, Fetal Death, Hematopoiesis, Proteins, Repressor Proteins, Transcription Factors, DNA Primers, Suppressor of Cytokine Signaling Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review